AnaptysBio, Inc.
ANAB
$43.63
-$0.13-0.30%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 242.81% | -19.83% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 242.81% | -19.83% | |||
| Cost of Revenue | -16.97% | -8.15% | |||
| Gross Profit | 388.63% | -16.05% | |||
| SG&A Expenses | -3.77% | -24.92% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.08% | -12.43% | |||
| Operating Income | 232.61% | 4.97% | |||
| Income Before Tax | 139.16% | 1.77% | |||
| Income Tax Expenses | -- | -11.36% | |||
| Earnings from Continuing Operations | 139.12% | 1.78% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 139.12% | 1.78% | |||
| EBIT | 232.61% | 4.97% | |||
| EBITDA | 233.87% | 4.98% | |||
| EPS Basic | 140.50% | -4.48% | |||
| Normalized Basic EPS | 140.54% | -4.49% | |||
| EPS Diluted | 138.78% | -4.48% | |||
| Normalized Diluted EPS | 138.88% | -4.49% | |||
| Average Basic Shares Outstanding | -3.39% | -5.98% | |||
| Average Diluted Shares Outstanding | 0.72% | -5.98% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||